Amaroq Ltd. logo

Amaroq Ltd. (AMRQF)

Market Closed
10 Aug, 20:00
OTC PINK OTC PINK
LSE LSE Primary XDUS XDUS
OTC PINK OTC PINK
XFRA XFRA XMUN XMUN
$
1. 42
-0.02
-1.3889%
$
202.06M Market Cap
- P/E Ratio
- Div Yield
1,050 Volume
- Eps
$ 1.44
Previous Close
Add Transaction
Day Range
1.42 1.43
Year Range
0.8 2.2
Want to track AMRQF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free

Summary

AMRQF closed today lower at $1.42, a decrease of -1.3889% from yesterday's close, completing a monthly increase of 26.7857% or $0.3. Over the past 12 months, AMRQF stock lost -2.069%.
AMRQF is not paying dividends to its shareholders.
The last earnings report, released on Mar 26, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0028%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on LSE (GBX).

AMRQF Chart

No Data

People also search for

AONC
American Oncology Network Inc.
$ 10
0%
NWBO
Northwest Biotherapeutics Inc.
$ 0.19
+5.5555%
CYBQY
Cyberdyne Inc. Sponsored ADR
$ 1.36
0%
IMPZY
Implanet S.A. Sponsored ADR
$ 0.08
0%
XVIPY
Xvivo Perfusion AB American Depositary Receipt
$ 7.13
+9.0031%

Amaroq Ltd. (AMRQF) FAQ

What is the stock price today?

The current price is $1.42.

On which exchange is it traded?

Amaroq Ltd. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is AMRQF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 202.06M.

Has Amaroq Ltd. ever had a stock split?

No, there has never been a stock split.

Amaroq Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
OTC PINK Exchange
CA02311U1030 ISIN
Germany Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Viromed Medical AG, formerly known as Fonterelli SPAC2 AG, is a pioneering company based in Pinneberg, Germany. Since its incorporation in 2021, the company has focused on the development and distribution of innovative products across diagnostics, therapeutics, and cold plasma technology. With a mission to revolutionize medical solutions and healthcare, Viromed Medical AG is positioned at the cutting edge of medical technology, committed to improving patient outcomes through its advanced product offerings and research initiatives.

Products and Services

  • Diagnostics

    Viromed Medical AG offers a range of diagnostic tools and kits designed for the detection and monitoring of various diseases. These products leverage the latest advancements in biotechnology to provide accurate, timely, and cost-effective diagnostic solutions for healthcare providers and patients alike.

  • Therapeutics

    The company develops and distributes a variety of therapeutic products aimed at treating and managing a wide spectrum of conditions. By focusing on innovation and efficacy, Viromed Medical AG delivers novel therapeutic options that contribute to better health outcomes and improve the quality of life for patients undergoing treatment.

  • Cold Plasma Technology

    One of Viromed Medical AG's most groundbreaking service areas is the application of cold plasma technology in medicine. This cutting-edge technology offers a non-invasive, highly effective approach to sterilization, wound healing, and possibly even cancer treatment. Cold plasma technology represents a significant step forward in medical science, showcasing Viromed Medical AG's commitment to leading the way in healthcare innovation.

Contact Information

Address: Flensburger Straße 18
Phone: 49 4101 809960
Download app banner
Blog Affiliate Program About Terms Privacy Help Contact Us
2026 © Marketlog. All Rights Reserved.
Play store app banner Play store app banner dark App store app banner App store app banner dark